Sulforaphane, Oxidative Stress, and NLRP3 in Colitis
2026-09-08
A 2024 mouse study shows that Sulforaphane can reduce dextran sodium sulfate-induced colitis while suppressing oxidative stress and NLRP3 inflammasome activation. Its value lies in connecting reactive oxygen species with inflammasome-associated cytokine release across animal and macrophage experiments, while leaving direct molecular targeting and clinical translation unresolved.
PDGF-BB Workflow for Vascular Remodeling Assays
2026-09-08
Build more reproducible vascular remodeling experiments with murine recombinant PDGF-BB, from dose-response proliferation assays to hypoxia-linked pulmonary hypertension models. This workflow connects receptor-aware stimulation with the ALDOB lactylation–mitochondrial fission findings reported in a recent reference study.
O-propargyl-puromycin (OPP) for Protein Synthesis
2026-09-07
O-propargyl-puromycin (OPP) converts a short translation pulse into a measurable signal for single-cell, imaging, and proteomics workflows. Applied to the Pcbp1–mitochondrial integrity problem in B cells, it can distinguish impaired protein production from changes in cell abundance or antibody secretion.
Hydroxychloroquine Sulfate Workflow Guide
2026-09-07
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous research reagent for examining autophagy pathway modulation and TLR7/9-associated immune responses in autoimmune disease research. It is suitable for locally validated cellular and animal workflows, but not for DMSO- or ethanol-based stocks or long-term storage of prepared solutions.
Y-27632: From Cytoskeletal Control to Translation
2026-09-05
Y-27632 offers translational researchers a reversible, selective way to interrogate ROCK-dependent cytoskeletal state while separating mechanical effects from MEK/ERK–c-Myc:MAX regulation of TERT in human pluripotent stem cells. This article presents a practical framework for experimental validation, model selection, and responsible interpretation across stem cell and cancer biology research.
AO/PI Staining Solution: 5 Lab Scenarios
2026-09-04
This scenario-driven guide explains how AO/PI Staining Solution (SKU K2269) supports accurate live dead cell discrimination, fluorescence-based cell counting, and cytotoxicity workflows. It connects membrane-integrity measurements with practical assay design, storage, interpretation, and vendor-selection decisions.
Bay 11-7821: NF-κB Assay Design in Tumor Immunology
2026-09-04
Bay 11-7821 (BAY 11-7082) offers a mechanistic way to test how IKK–NF-κB signaling shapes macrophage–T-cell interactions in cancer research. This article translates recent radiotherapy and checkpoint-blockade findings into rigorous assay decisions without overstating what a chemical inhibitor can prove.
Ruxolitinib Workflows for JAK-STAT Research
2026-09-03
Ruxolitinib (INCB018424) combines nanomolar JAK1/JAK2 activity with practical utility in progenitor, myelofibrosis, and immune-oncology assays. This guide translates pathway inhibition into reproducible dosing, phospho-signaling, colony, and high-dimensional spectral-flow workflows while separating established evidence from cross-domain experimental opportunities.
GSH-Responsive MOF Nanoparticles for Melanoma Therapy
2026-09-03
Hao and colleagues developed ICG-MOF-SS-AUNP12, a glutathione-responsive metal-organic framework nanoparticle that combines photothermal ablation with localized PD-1/PD-L1 blockade. The study shows how 808 nm irradiation, redox-triggered peptide release, and immune activation can be integrated into one melanoma-oriented nanoplatform, while also highlighting the validation needed before substituting related dyes such as IR-820.
4-Hydroxytamoxifen: Protocol and QC Guide
2026-09-02
4-Hydroxytamoxifen is a DMSO-compatible estrogen receptor modulator for controlled cell, cancer, cardiac myocyte, and selected mouse-model workflows. It should not be selected for protocols requiring water or ethanol as the primary solvent, and long-term storage of prepared solutions should be avoided.
CDK9 inhibitor A3294: Practical Workflow Guide
2026-09-02
CDK9 inhibitor A3294 provides a selective serine/threonine kinase inhibitor for examining CDK9-dependent transcription elongation, P-TEFb activity, and exploratory HIV-1 propagation assays. The available evidence is limited to the product dossier, so it should be validated in the intended assay and should not be treated as a pan-CDK reagent, universal cytotoxicity control, or therapeutic predictor.
Leupeptin: Precision Protease Control in Translation
2026-09-01
Leupeptin hemisulfate salt is more than a conventional protease-blocking reagent. Its reversible, competitive mechanism provides a controllable way to interrogate protein degradation, autophagy, and selected viral replication workflows, while a modern TET2 metabolite-binding protocol offers a useful model for orthogonal validation and translational assay design.
RepSox: ALK5 Inhibition in iPSC Workflows
2026-09-01
RepSox is a potent and selective ALK5 inhibitor for studying TGF-β signaling, induced pluripotent stem cell reprogramming, and cell differentiation. Its reported 4 nM ALK5 inhibition supports pathway-focused experiments, but current hiPSC-derived platelet benchmarks do not establish RepSox as a validated platelet-differentiation reagent.
Liproxstatin-1 in Ferroptosis Assay Design
2026-08-31
Liproxstatin-1 is a potent ferroptosis inhibitor for testing whether lipid peroxidation drives cell injury. This guide connects its validated rescue profile with a sex-specific salivary gland study and offers a causal, tissue-aware assay strategy.
0.4% Trypan Blue Solution: Practical Guide
2026-08-31
0.4% Trypan Blue Solution supports rapid cell viability measurement by differentiating unstained viable cells from blue-stained dead or membrane-damaged cells during cell counting. It is suitable for research workflows and cytotoxicity assays, but it should not be used for diagnostic purposes or as a standalone method for mechanistic apoptosis and necrosis detection.
562 records 6/38 page Previous Next First page 上5页 678910 下5页 Last page